Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.533845523747652 | N/A |
Market Cap | $219.22M | N/A |
Shares Outstanding | 410.64M | N/A |
Employees | 365.00 | N/A |